Lansoprazole Capsule, Delayed Release
Product Images NDC 68071-3870

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68071-3870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3870 3)

Label for Lansoprazole 30 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label indicates a #30 capsule count with a red header displaying the manufacturer name. It includes NDC 68071-3870-3, barcode, storage instructions at controlled temperature (68-77°F), and warnings to keep out of reach of children. Additional manufacturer and packaging information references Xiromed LLC and Packaged by NuCare Pharmaceuticals.*

FDA Label Image

Figure-1.jpg (Figure 1)

A line graph showing the mean severity of day heartburn over time for evaluable patients, comparing placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. The x-axis represents days from the start of treatment (-5 to 60), and the y-axis represents mean severity of day heartburn on a scale from 0 (none) to 3 (severe). Lansoprazole groups show a decrease in heartburn severity compared to placebo.*

FDA Label Image

Figure-2.jpg (Figure 2)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients,' plotting mean severity (scale 0-3) on the vertical axis against days from start of treatment (-5 to 60) on the horizontal axis. It compares Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups, showing reduced severity over time with Lansoprazole treatments versus placebo.*

FDA Label Image

Formula-structure.jpg (Image 01)

Chemical structure of lansoprazole, showing its molecular formula with distinct functional groups including a benzimidazole ring, sulfoxide group, and trifluoromethoxy substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.